One day after the office of Attorney General William Tong announced Connecticut’s Medicaid program would receive $1.3 million of a $75 million multistate settlement with Bristol-Myers Squibb related to Medicaid overcharges, state officials reacted to the news and had harsh words for the pharmaceutical manufacturer.
In a statement, Tong said the settlement, which some governments announced in April, but states such as Connecticut and California announced Tuesday, should be a deterrent to other companies.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]